Follow
Daniel Alcalá López
Daniel Alcalá López
Medica Scientia Innovation Research (MEDSIR)
Verified email at medsir.org
Title
Cited by
Cited by
Year
Computing the social brain connectome across systems and states
D Alcalá-López, J Smallwood, E Jefferies, F Van Overwalle, K Vogeley, ...
Cerebral cortex 28 (7), 2207-2232, 2018
1722018
Building blocks of social cognition: Mirror, mentalize, share?
D Alcalá-López, K Vogeley, F Binkofski, D Bzdok
Cortex 118, 4-18, 2019
762019
3-year invasive disease-free survival (iDFS) of the strategy-based, randomized phase II PHERGain trial evaluating chemotherapy (CT) de-escalation in human epidermal growth …
J Cortes, JM Pérez-García, M Ruiz-Borrego, A Stradella, B Bermejo, ...
Journal of Clinical Oncology 41 (17_suppl), LBA506-LBA506, 2023
172023
Second-line endocrine therapy (ET) with or without palbociclib (P) maintenance in patients (pts) with hormone receptor-positive (HR [+])/human epidermal growth factor receptor …
A Llombart-Cussac, C Harper-Wynne, A Perello, A Hennequin, ...
Journal of Clinical Oncology 41 (16_suppl), 1001-1001, 2023
162023
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study
Cancers 14 (5880), 2022
52022
Phase II study of the efficacy of retifanlimab (Rf)(INCMGA00012) in penile squamous cell carcinoma (PSqCC): ORPHEUS final analysis.
X Garcia del Muro, MA Cuellar, P Maroto-Rey, P Giannatempo, ...
Journal of Clinical Oncology 41 (16_suppl), 5043-5043, 2023
22023
Decoding social knowledge in the human brain
D Alcalá-López, D Soto
bioRxiv, 2020.08. 18.255513, 2020
22020
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast …
JM Pérez-García, J Cortés, M Ruiz-Borrego, M Colleoni, A Stradella, ...
The Lancet, 2024
12024
Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial
A Llombart-Cussac, JM Pérez-Garcia, MR Borrego, P Tolosa, S Blanch, ...
EClinicalMedicine 71, 2024
2024
Brain wide representation of social knowledge
D Alcala-López, N Mei, P Margolles, D Soto
PsyArXiv, 2023
2023
A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer
M Sampayo-Cordero, B Miguel-Huguet, A Malfettone, E López-Miranda, ...
Frontiers in Oncology 13, 2023
2023
Physiopy: A community-driven suite of tools for physiological recordings in neuroimaging
KL Bottenhorn, D Alcalà-Lopez, A Ayyagari, MG Bright, ...
The system can't perform the operation now. Try again later.
Articles 1–12